Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · IEX Real-Time Price · USD
41.82
+0.43 (1.04%)
Jul 22, 2024, 9:31 AM EDT - Market open
Dyne Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$42.56
Upside
+1.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $39 → $43 | Buy | Maintains | $39 → $43 | +2.82% | Jul 9, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $31 → $42 | Strong Buy | Maintains | $31 → $42 | +0.43% | May 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $46 → $48 | Strong Buy | Maintains | $46 → $48 | +14.78% | May 20, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | -25.87% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $47 | Buy | Reiterates | $47 | +12.39% | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | May 3, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | -4.35% | Apr 30, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $47 | Buy | Reiterates | $47 | +12.39% | Mar 26, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $31 | Strong Buy | Maintains | $20 → $31 | -25.87% | Mar 8, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $33 → $37 | Strong Buy | Maintains | $33 → $37 | -11.53% | Mar 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | -13.92% | Mar 6, 2024 |
| Stifel | Stifel | Strong Buy Maintains $35 → $41 | Strong Buy | Maintains | $35 → $41 | -1.96% | Mar 6, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | -30.66% | Mar 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $44 → $47 | Buy | Reiterates | $44 → $47 | +12.39% | Mar 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | -13.92% | Feb 20, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $27 → $56 | Strong Buy | Maintains | $27 → $56 | +33.91% | Jan 4, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | -47.39% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | -52.18% | Aug 4, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $20 | Strong Buy | Maintains | $17 → $20 | -52.18% | Mar 3, 2023 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $16 → $27 | Buy → Strong Buy | Upgrades | $16 → $27 | -35.44% | Feb 27, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $34 | Buy | Initiates | $34 | -18.70% | Feb 15, 2023 |